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The RNAs of hepatitis C virus (HCV) isolates from 62 patients with chronic HCV infection were analyzed by
direct sequencing of the 5' untranslated region. Two important sequence motifs were recognized: one between
positions -170 and -155 and the other between positions -132 and -117. These motifs are partly
complementary. All three previously published genotypes were observed; 34 (55%) isolates were classified as
type 1 (including prototype [from the United States] and HCV-BK [from Japan] sequences), 11 (18%) were
classified as type 2 (including HC-J6 and HC-J8), and 12 (19%o) were classified as type 3 (including EB1); one
patient was infected with genotypes 1 and 2. Four (6%) isolates showed aberrant sequences and were therefore
provisionally classified as genotype 4. These results indicate the significance of sequence variation among the
5' untranslated regions of different HCV genotypes and indicate that this region could possibly be used for
consistent genotyping of HCV isolates.
Since the discovery of hepatitis C virus (HCV), a flavi-like
virus with a positive-sense, single-stranded RNA genome of
approximately 9,400 nucleotides (6), several full-length se-
quences have been obtained from various isolates (7, 14, 21,
22, 26) and investigators have proposed (3, 4, 9, 12, 18, 21)
that HCV isolates be classified into different types or sub-
types. On the basis of all available sequence information,
Chan et al. (4) distinguished three HCV genotypes. Type 1
isolates include the prototype strain HCV-1 (7) and strains
HCV-H (19), HCV-K1 (9), HCV-J (14), and HCV-BK (26);
type 2 includes strains HCV-K2 (9), HC-J6 (22), and HC-J8
(21); type 3 includes strains HCV E-bl (4), HCV-T (18), and
HCV1196 (17).
HCV genotyping is of interest in viral transmission studies
and HCV epidemiology. Furthermore, the success of inter-
feron treatment (25, 28) may be type or subtype related.
There are several reasons to choose the 5' untranslated
region (5' UTR) for genotyping. (i) Analysis of a large
number of HCV isolates results in similar phylogenetic trees
for the 5' UTR, the core, NS-3, and NS-5 regions (4); (ii) the
observed mutation rate of the 5' UTR is extremely low (19,
20); (iii) sequence variation within the conserved 5' UTR is
mainly limited to specific regions; and (iv) the putative
secondary structure of the 5' UTR, as established from
biochemical and phylogenetic data (1), suggests functional
conservation of this region.
In the study described here, the RNAs of 62 HCV isolates
from patients in The Netherlands with chronic HCV infec-
tions were investigated to determine whether HCV genotyp-
ing by sequence analysis of PCR products derived from the
5' UTR could be performed.
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MATERIALS AND METHODS
Patients. Sixty-two patients from The Netherlands be-
tween the ages of 26 and 74 years with elevated alanine
aminotransferase levels, a biopsy-proven chronic non-A,
non-B hepatitis, antibodies to HCV, and no recent history of
infection with hepatitis B virus, hepatitis A virus, cytomeg-
alovirus, or Epstein-Barr virus were analyzed.
Anti-HCV. Antibodies to HCV were tested by a second-
generation enzyme immunoassay (Abbott, North Chicago,
Ill.) and were confirmed by the recombinant immunoblot
assay (RIBA-4; Ortho Diagnostics, Raritan, N.J.) according
to the instructions of the manufacturer.
Blood plasma. For HCV RNA detection, EDTA-blood was
collected by venipuncture, and plasma was prepared within
2 h after sampling. One-milliliter aliquots were quickly
frozen in liquid nitrogen and were stored at -70°C until use.
HCV RNA PCR. HCV RNA was isolated from 100 ,ul of
plasma by a modified version of the guanidinium method
described previously (5). cDNA synthesis was performed on
one-third of the isolated RNA in a 25-,u reaction volume (15)
by using 20 pmol of antisense primer HCV19 (GTGCACG
GTCTACGAGACCT; positions -1 to -20), 200 U of Molo-
ney murine leukemia virus reverse transcriptase (GIBCO-
Bethesda Research Laboratories, Gaithersburg, Md.), 30 U
of RNAsin (Promega, Madison, Wis.), and 0.5 mM (each)
deoxyribonucleotide (Boehringer, Mannheim, Germany) at
42°C for 30 min after brief denaturation at 80°C. PCR was
performed (40 cycles of 1 min at 94°C, 2 min at 48°C, and 3
min at 74°C) with the antisense primer HCV19 and the sense
primer HCV18 (GGCGACACTCCACCATAGAT; positions
-304 to -324) or the sense primer HCV35 (TTGGCGGC
CGCACTCCACCATGAATCACTCCCC; positions -296 to
-318; underlined sequences are not complementary to the
HCV sequence). For diagnosis, the first-round PCR prod-
ucts were analyzed by Southern blot hybridization with
probe HCV17 (GAGTAGTGTTGGGTCGCGAA; positions
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-86 to -67); this was followed by washing at low strin-
gency.
Direct sequencing of PCR products. For direct sequencing
of PCR products (13), a second round of PCR (40 cycles of 1
min at 94°C, 2 min at 48°C, and 3 min at 74°C) was performed
with the sense primer NCR3 (GGGGCGGCCGCCACCA
TRRATCACTCCCCTGTGAGG; positions -288 to -314)
and the antisense primer LD58 (5'-bio-GGCCGGGGCGGC
CGCCAAGCACCCTATCAGGCAGTACCACAAGGC; po-
sitions -37 to -64). LD58 is biotinylated at the 5' end.
Biotinylated PCR products (estimated by agarose gel elec-
trophoresis at approximately 100 ng) were captured on
streptavidin-coated paramagnetic particles (Dynabeads
M-280; Dynal, Oslo, Norway). Single-stranded DNA was
prepared by denaturation of the captured amplification prod-
uct by alkaline treatment according to the instructions of
Dynal. Separate strands were sequenced by using the T7
DNA sequencing kit (Pharmacia, Uppsala, Sweden) and
[32P]dATP (Amersham, Buckinghamshire, United King-
dom). NCR3 served as a sense primer on the minus strand
captured on the beads, and NCR4 (CACTCTCGAGCAC
CCTATCAGGCAGTACC; positions -57 to -29) was used
as the antisense primer on the plus strand in the supernatant.
DNA sequences were read manually from autoradiographs
and were analyzed with the PC/Gene computer program
(Intelligenetics Inc., Mountain View, Calif.).
Nucleotide sequence accession number. The nucleotide
sequences reported here have been deposited in the EMBL
data library (accession numbers X58937 to X58953).
RESULTS
Sixty-two patients with chronic HCV infection were anti-
HCV positive by enzyme immunoassay which was con-
firmed by RIBA-4, and were HCV RNA positive by reverse
transcription-PCR aimed at the 5' UTR. The sense primer
HCV18, which was based on the first published HCV
sequences (10, 23), was initially used for the diagnosis of
HCV viremia by PCR. In the case of low yields of PCR
products, the sense primer HCV35 improved the PCR re-
sults considerably (data not shown), and in these cases, PCR
products obtained by HCV35 were used for sequence anal-
ysis.
Nested PCR products were sequenced directly, and the
results are presented in Fig. 1. If identical sequences were
obtained from a number of isolates, only one representative
sequence is shown. Several sequences have been reported
previously and are identified by their original names. Lim-
ited sequence variations were observed essentially in two
motifs: motif 1 is located between nucleotides (nt) -170 and
-155, and motif 2 is located between nt -132 and -117 (Fig.
1). On the basis of these motifs, 58 of 62 isolates could be
classified into the three genotypes as proposed previously.
Thirty-four (55%) isolates were classified as type 1; this
included the prototype HCV sequence HCV-1. Isolate
HC1-N8 showed a single insertion at nt -138. In one patient
(isolate HC1/2), a double infection with types 1 and 2 was
observed, as deduced from bands with identical mobilities in
two different lanes on the gel (Fig. 2). Type 2 sequences,
including the sequence of HC-J6, were observed in 11 (18%)
patients. These isolates were also recognized by the pres-
ence of a T at position -72 and a C at position -80. HC2-N2
contained a mutation at nt -127 in motif 2. Within genotype
2, sequence heterogeneity was observed at position -119,
showing either a T or C. Type 3 sequences were detected in
12 (19%) patients. In addition to the type-specific sequence
motifs, type 3 isolates could also be identified by a TCA
sequence at positions -93 to -95. HC3-N2 contained a point
mutation at position -118 in motif 2. Four (6%) isolates were
provisionally classified as type 4. These isolates showed
additional sequence heterogeneity between positions -238
and -235 in comparison with the sequences of strains of
types 1, 2, and 3.
Comparison between the sequences obtained in the
present study (nt -262 to -66) and all previously reported 5'
UTR sequences (2-4, 11) revealed a number of new 5' UTR
mutations within all genotypes (Fig. 1).
The overall sequence heterogeneity among the four geno-
types in the present study ranged from 4% between types 1
and 4 to 11% between types 2 and 3, whereas heterogeneity
within each type was less than 2.5% (Table 1). Mutations
were not randomly distributed along the 5' UTR but were
clustered in motifs 1 and 2. Comparison of these motifs
among the four genotypes revealed strong conservation
within each genotype and showed significant differences
between the genotypes (Table 1). Further analysis of the
sequence variation in motifs 1 and 2 revealed the presence of
covariants, i.e., compensatory mutations in each motif,
maintaining the postulated secondary structure of the 5'
UTR genomic RNA (1). The P values for the occurrence of
one, two, or three covariant mutations in motifs 1 and 2 to
have arisen by chance were very low (P = 0.06, P = 0.004,
and P = 0.0002, respectively). Covariance occurred at
positions -164, -163, -161, and -155 in motif 1 and
positions -132, -124, -122, and -121 in motif 2. This
covariance was consistently observed in the sequences of all
62 isolates, indicating the importance of this phenomenon.
DISCUSSION
Sequence analysis of the 5' UTR of HCV isolates from 62
patients with chronic HCV infection allowed consistent and
efficient genotyping. Fifty-eight (94%) isolates could be
classified into the three different genotypes proposed by
Chan et al. (4). Identification of the genotypes is essentially
based on the sequence variation in the defined motifs 1 and
2.
All three genotypes reported so far were observed in the
HCV-infected patient population in The Netherlands. The
coexistence ofHCV genotypes in several geographic regions
has been indicated earlier (3, 4). However, little is known
about the distribution of HCV genotypes in Europe. The
majority of published isolates belong to type 1 (8, 16). Types
2 and 3 were detected in European isolates only recently (2,
4).
Isolates belonging to a new genotype, tentatively desig-
nated genotype 4, were observed in The Netherlands, al-
though at a low frequency. Similar sequences were first
found in isolates from South Africa (3) and Denmark (2). To
justify classification of these isolates as a new genotype 4,
sequence analysis of the coding regions is necessary. Pre-
liminary results (data not shown) indicate significant nucle-
otide sequence differences between the core region from
type 4 isolates and the corresponding sequences from type 1,
2, and 3 isolates. One sequence (SA1), classified here as type
4, showed minor differences with the other type 4 sequences
and might be classified as a separate genotype, genotype 5
(25a). All genotypes probably have a worldwide distribution,
but the relative abundances per geographic region may differ
considerably.
A double infection involving genotypes 1 and 2 was found
in one patient. This was in accordance with the reported
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FIG. 1. Alignment of 5' UTR sequences from 62 patients. Sequences between positions -262 and -66 were classified into genotypes 1,
2, and 3 (as proposed by Chan et al. [4]) and genotype 4. Previously published sequences are identified by their original names: HCV-1 (7);
DK7, SA10, US10, SA1, and DK13 (2); HCV-BK (26); HC-J6 (22); EB-12 and EB-7 (4); and HCV1196 (17). Numbers in parentheses indicate
the number of isolates with that sequence. Hyphens indicate the presence of nucleotides identical to those of the prototype strains. Characters
in boldface type are newly obtained point mutations. Sequence motifs 1 and 2 are boxed. H underlined nucleotides in the HCV-1 sequence
are involved in the putative double-stranded RNA stem structure (1). Abbreviations: M, A or C; R, A or G; Y, T or C; W, A or T; and S,
G or C.
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frequency of double infections which has been observed by
others (24, 28) by using type-specific primers or probes.
New 5' UTR sequences were observed in 21 of the 62
isolates analyzed. The distribution of the sequence variation
was not random. Recently, the putative secondary structure
and possible functional elements of the 5' UTR of the HCV
genome were postulated (1, 27, 29). The defined sequence
motifs 1 and 2 show partial complementarity and are able to
form a stable stem-loop structure; e.g., nt A at position -170
is complementary to nt T at position -115, and nt C (or T for
type 2) at position -155 is complementary to nt G (or A for
type 2) at position -132. Covariance in motifs 1 and 2
consistently preserves the secondary structure. Therefore,
mutations are more likely to be tolerated in single-stranded
regions. This is confirmed by the relatively high mutation
rate in the single-stranded RNA loop between positions
TABLE 1. Mean nucleotide variation among four HCV
genotypes in the entire 197-bp 5' UTR
fragment and motifs 1 and 2
Fragment and No. of % Nucleotide variation
genotype isolatese 1 2 3 4
197-bp 5' UTR
1 34 2.5
2 11 7.1 2.0
3 12 7.1 11.2 1.0
4 4 4.1 6.1 6.1 2.0
Motifs 1 and 2
1 34 0
2 11 28.0 2.5
3 12 28.0 35.5 0.3
4 4 12.5 23.5 15.8 1.5
a Sixty-one HCV isolates were analyzed for sequence variation in 197-bp
fragments from the 5' UTR (nt -262 to -66).
G A T C
-110 -
Aia&
w-
U_
motif 2
motif I
-170 -
FIG. 2. Direct sequence analysis of the 5' UTR from isolate
HC1/2 with the sense primer NCR3. Abbreviations: S, G or C; W, A
or T; Y, T or C; R, A or G; and M, A or C.
-136 and -151. Most of the point mutations are located
outside of the defined sequence motifs and do not affect
classification. Only two isolates showed single point muta-
tions within the two motifs: HC2-N2 contained a G at
position -127, and HC3-N2 contained a C at position -118.
Despite these variations, classification of HC2-N2 and
HC3-N2 as types 2 and 3, respectively, was obvious.
The overall sequence variation between the 197-bp 5'
UTR fragments was not statistically significant, because
only 6 to 21 mutations were observed among the four
genotypes. Because the mutations were not randomly dis-
tributed along the 5' UTR, it is impossible to apply regular
statistical methods to this problem, because these require a
random distribution of events. The secondary structure, i.e.,
the stem-loop structure formed by the partial complementa-
rity of motifs 1 and 2, must be maintained (with a sufficiently
low free energy) to function properly as an internal riboso-
mal entry site (27). Therefore, mutations in these motifs have
functional restrictions. Comparison of the 5' UTR sequences
described in this report reveals the existence of covariants.
These complementary mutations in motifs 1 and 2 indeed
completely conserve the secondary structure, indicating the
significance of covariance. On the basis of these findings,
HC1-N1
HCV-1
HC1-N2
HC1-N3
DK7
HC1-N4
HC1-N5
HC1-N6
HCV-BK
HC1-N7
SA10
HC1-N8
HC1/2
Us1o
HC2-N1
HC-J6
HC2-N2
EB12
HC3-N1
HCV1196
HC3-N2
EB7
HC3-N3
HC3-N4
HC3-N5
SAl
HC4-N1
DK13
HC4-N2
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classification of HCV isolates should preferably be based on
covariance in motifs 1 and 2.
In conclusion, consistent genotyping based on 5' UTR
sequence analysis is possible and may complement studies
on antiviral treatment and the transmission of HCV.
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